145 related articles for article (PubMed ID: 35090306)
1. Identification of differentially expressed genes and pathways for risk stratification in HPV-associated cancers governing different anatomical sites.
Kwon EJ; Lee HR; Lee JH; Seo C; Ha M; Roh J; Kim YH; Jang JY
Front Biosci (Landmark Ed); 2022 Jan; 27(1):2. PubMed ID: 35090306
[TBL] [Abstract][Full Text] [Related]
2. Identification and Complete Validation of Prognostic Gene Signatures for Human Papillomavirus-Associated Cancers: Integrated Approach Covering Different Anatomical Locations.
Kwon EJ; Ha M; Jang JY; Kim YH
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361419
[TBL] [Abstract][Full Text] [Related]
3. Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
Ekanayake Weeramange C; Shu D; Tang KD; Batra J; Ladwa R; Kenny L; Vasani S; Frazer IH; Dolcetti R; Ellis JJ; Sturm RA; Leo P; Punyadeera C
Cancer; 2022 May; 128(10):1937-1947. PubMed ID: 35176174
[TBL] [Abstract][Full Text] [Related]
4. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.
Pyeon D; Newton MA; Lambert PF; den Boon JA; Sengupta S; Marsit CJ; Woodworth CD; Connor JP; Haugen TH; Smith EM; Kelsey KT; Turek LP; Ahlquist P
Cancer Res; 2007 May; 67(10):4605-19. PubMed ID: 17510386
[TBL] [Abstract][Full Text] [Related]
5. NF-κB1 Intronic Region Polymorphisms as Risk Factor for Head and Neck Cancer in HPV-Infected Population from Pakistan.
Sarwar S; Tareen MU; Sabir M; Sultan A; Malik SA
Curr Mol Med; 2022; 22(1):74-82. PubMed ID: 33653249
[TBL] [Abstract][Full Text] [Related]
6. Identification of the HNSC88 Molecular Signature for Predicting Subtypes of Head and Neck Cancer.
Chuang YH; Lin CY; Lee JC; Lee CH; Liu CL; Huang SH; Lee JY; Lai WS; Yang JM
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685875
[TBL] [Abstract][Full Text] [Related]
7. The tumor immune microenvironments of HPV
Gameiro SF; Evans AM; Mymryk JS
WIREs Mech Dis; 2022 Mar; 14(2):e1539. PubMed ID: 35030304
[TBL] [Abstract][Full Text] [Related]
8. Identification of human papillomavirus status specific biomarker in head and neck cancer.
Kim KY; Zhang X; Cha IH
Head Neck; 2015 Sep; 37(9):1310-8. PubMed ID: 24817691
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial outcomes of human papillomavirus (HPV)- and non-HPV-related head and neck cancers: A longitudinal study.
Henry M; Arnovitz E; Frenkiel S; Hier M; Zeitouni A; Kost K; Mlynarek A; Black M; MacDonald C; Richardson K; Mascarella M; Morand GB; Chartier G; Sadeghi N; Rosberger Z
Psychooncology; 2022 Feb; 31(2):185-197. PubMed ID: 35122670
[TBL] [Abstract][Full Text] [Related]
10. Current Status of Human Papillomavirus-Related Head and Neck Cancer: From Viral Genome to Patient Care.
Dong H; Shu X; Xu Q; Zhu C; Kaufmann AM; Zheng ZM; Albers AE; Qian X
Virol Sin; 2021 Dec; 36(6):1284-1302. PubMed ID: 34152564
[TBL] [Abstract][Full Text] [Related]
11. A Current Update on Human Papillomavirus-Associated Head and Neck Cancers.
Tumban E
Viruses; 2019 Oct; 11(10):. PubMed ID: 31600915
[TBL] [Abstract][Full Text] [Related]
12. Reduced MHC Class I and II Expression in HPV-Negative vs. HPV-Positive Cervical Cancers.
Evans AM; Salnikov M; Tessier TM; Mymryk JS
Cells; 2022 Dec; 11(23):. PubMed ID: 36497170
[TBL] [Abstract][Full Text] [Related]
13. HPV-related methylation-based reclassification and risk stratification of cervical cancer.
Yang S; Wu Y; Wang S; Xu P; Deng Y; Wang M; Liu K; Tian T; Zhu Y; Li N; Zhou L; Dai Z; Kang H
Mol Oncol; 2020 Sep; 14(9):2124-2141. PubMed ID: 32408396
[TBL] [Abstract][Full Text] [Related]
14. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
[TBL] [Abstract][Full Text] [Related]
15. Investigation of molecular mechanisms underlying JAK/STAT signaling pathway in HPV-induced cervical carcinogenesis using 'omics' approach.
Thakur K; Janjua D; Shishodia G; Chhokar A; Aggarwal N; Yadav J; Tripathi T; Chaudhary A; Senrung A; Bharti AC
Med Oncol; 2022 Oct; 39(12):255. PubMed ID: 36224441
[TBL] [Abstract][Full Text] [Related]
16. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas.
Kong CS; Narasimhan B; Cao H; Kwok S; Erickson JP; Koong A; Pourmand N; Le QT
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):553-61. PubMed ID: 19427557
[TBL] [Abstract][Full Text] [Related]
17.
Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
[TBL] [Abstract][Full Text] [Related]
18. Characteristic differences in radiation-induced DNA damage response in human papillomavirus-negative and human papillomavirus-positive head and neck cancers with accumulation of fractional radiation dose.
Reid P; Staudacher AH; Marcu LG; Olver I; Moghaddasi L; Brown MP; Bezak E
Head Neck; 2021 Oct; 43(10):3086-3096. PubMed ID: 34235809
[TBL] [Abstract][Full Text] [Related]
19. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus (HPV) DNA methylation changes in HPV-associated head and neck cancer.
Ekanayake Weeramange C; Tang KD; Irwin D; Hartel G; Langton-Lockton J; Ladwa R; Kenny L; Taheri T; Whitfield B; Vasani S; Punyadeera C
Carcinogenesis; 2024 Mar; 45(3):140-148. PubMed ID: 38270218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]